Background People living with human immunodeficiency virus (PLWH) are characterized by
excess risk of cardiovascular diseases (CVD) and CVD risk factors compared to uninfected …

Metabolic complications such as dyslipidemia, insulin resistance, and altered fat distribution
(loss of subcutaneous fat and relatively increased central fat) are common in adults infected …

Objective: This study assessed the effect of obesity on metabolic and cardiovascular disease
risk factors in HIV-infected adults on antiretroviral therapy with sustained virologic …

Background: Obesity and HIV infection are ongoing epidemics in the United States. Obesity
predisposes to diabetes and cardiovascular disease, which are complications also …

Background Although half of HIV-infected patients develop lipodystrophy and metabolic
complications, there exists no simple clinical screening tool to discern the high from the low …

Background. Highly active antiretroviral therapy (HAART), in addition to traditional vascular
risk factors, may affect coronary heart disease (CHD) risk in individuals with human …

Background The prevalence and factors associated with overweight/obesity among human
immunodeficiency virus (HIV)-infected persons are unknown. Methods We evaluated …

Background. Individuals infected with human immunodeficiency virus (HIV) have a higher
risk of cardiovascular disease, potentially partly mediated by a higher prevalence of …

Background Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in
people with human immunodeficiency virus (PWH) is limited. We aimed to identify the risk of …

Background: Metabolic syndrome is a combination of risk factors for cardiovascular disease
and diabetes, It has been reported to be increased in human immunodeficiency virus (HIV) …